↓ Skip to main content

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Overview of attention for article published in The Lancet, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 42,983)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
1435 Dimensions

Readers on

mendeley
2098 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Published in
The Lancet, February 2021
DOI 10.1016/s0140-6736(21)00234-8
Pubmed ID
Authors

Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, Anna V Kovyrshina, Nadezhda L Lubenets, Daria M Grousova, Alina S Erokhova, Andrei G Botikov, Fatima M Izhaeva, Olga Popova, Tatiana A Ozharovskaya, Ilias B Esmagambetov, Irina A Favorskaya, Denis I Zrelkin, Daria V Voronina, Dmitry N Shcherbinin, Alexander S Semikhin, Yana V Simakova, Elizaveta A Tokarskaya, Daria A Egorova, Maksim M Shmarov, Natalia A Nikitenko, Vladimir A Gushchin, Elena A Smolyarchuk, Sergey K Zyryanov, Sergei V Borisevich, Boris S Naroditsky, Alexander L Gintsburg, Gam-COVID-Vac Vaccine Trial Group

X Demographics

X Demographics

The data shown below were collected from the profiles of 40,282 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2,098 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2098 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 320 15%
Researcher 261 12%
Student > Master 179 9%
Student > Ph. D. Student 163 8%
Other 116 6%
Other 366 17%
Unknown 693 33%
Readers by discipline Count As %
Medicine and Dentistry 502 24%
Biochemistry, Genetics and Molecular Biology 204 10%
Agricultural and Biological Sciences 98 5%
Immunology and Microbiology 93 4%
Pharmacology, Toxicology and Pharmaceutical Science 86 4%
Other 335 16%
Unknown 780 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25855. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#13
of 25,750,437 outputs
Outputs from The Lancet
#1
of 42,983 outputs
Outputs of similar age
#1
of 538,905 outputs
Outputs of similar age from The Lancet
#1
of 368 outputs
Altmetric has tracked 25,750,437 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,983 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 538,905 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 368 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.